Extract

The primary objective of the trial is to assess if using insulin detemir mixed with insulin aspart in the same syringe and 2 separates injections of insulin detemir and insulin aspart will have any clinical impact in the glycaemic control assessed by HbA1c after 8 weeks of treatment.

Inclusion criteria

• Investigating the glycaemic effect and profile in children with Type 1 diabetes

Links

• euctr
• ictrp